menu search

NMRA / Neumora Therapeutics to Participate in Upcoming Conferences in November

Neumora Therapeutics to Participate in Upcoming Conferences in November
WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced that the Company will participate in two investor conferences in November: Read More
Posted: Oct 30 2023, 07:00
Author Name: GlobeNewsWire
Views: 112294

NMRA News  

Neumora Therapeutics to Participate in Upcoming Conferences in November

By GlobeNewsWire
October 30, 2023

Neumora Therapeutics to Participate in Upcoming Conferences in November

WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining n more_horizontal

Why Shares of Neumora Therapeutics Slumped This Week

By The Motley Fool
September 21, 2023

Why Shares of Neumora Therapeutics Slumped This Week

Neumora focuses on central nervous system disorders. Its lead therapy is Navacaprant to treat MDD. more_horizontal


Search within

Pages Search Results: